WIP1 Phosphatase as a Potential Therapeutic Target in Neuroblastoma
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
WIP1 Phosphatase as a Potential Therapeutic Target in Neuroblastoma
Authors
Keywords
-
Journal
PLoS One
Volume 10, Issue 2, Pages e0115635
Publisher
Public Library of Science (PLoS)
Online
2015-02-07
DOI
10.1371/journal.pone.0115635
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mdm2 Deficiency Suppresses MYCN-Driven Neuroblastoma Tumorigenesis In Vivo
- (2015) Zaowen Chen et al. NEOPLASIA
- MDM2-p53 Interaction in Paediatric Solid Tumours: Preclinical Rationale, Biomarkers and Resistance
- (2014) Giuseppe Barone et al. CURRENT DRUG TARGETS
- Phosphatase WIP1 regulates adult neurogenesis and WNT signaling during aging
- (2014) Yunhua Zhu et al. JOURNAL OF CLINICAL INVESTIGATION
- Allosteric Wip1 phosphatase inhibition through flap-subdomain interaction
- (2014) Aidan G Gilmartin et al. Nature Chemical Biology
- Exome sequencing identifies somatic gain-of-function PPM1D mutations in brainstem gliomas
- (2014) Liwei Zhang et al. NATURE GENETICS
- Gain-of-function mutations of PPM1D/Wip1 impair the p53-dependent G1 checkpoint
- (2013) Petra Kleiblova et al. JOURNAL OF CELL BIOLOGY
- Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer
- (2012) Elise Ruark et al. NATURE
- Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes
- (2012) Jan J. Molenaar et al. NATURE
- A Genome-Wide Search for Promoters That Respond to Increased MYCN Reveals Both New Oncogenic and Tumor Suppressor MicroRNAs Associated with Aggressive Neuroblastoma
- (2011) J. M. Shohet et al. CANCER RESEARCH
- Functional Analysis of the p53 Pathway in Neuroblastoma Cells Using the Small-Molecule MDM2 Antagonist Nutlin-3
- (2011) T. Van Maerken et al. MOLECULAR CANCER THERAPEUTICS
- The Wip1 phosphatase and Mdm2: Cracking the "Wip" on p53 stability
- (2010) Xiongbin Lu et al. CELL CYCLE
- Dephosphorylation of γ-H2AX by WIP1: An important homeostatic regulatory event in DNA repair and cell cycle control
- (2010) Sung-Hwan Moon et al. CELL CYCLE
- High Frequency of p53/MDM2/p14ARF Pathway Abnormalities in Relapsed Neuroblastoma
- (2010) J. Carr-Wilkinson et al. CLINICAL CANCER RESEARCH
- Wild-type p53-induced Phosphatase 1 Dephosphorylates Histone Variant γ-H2AX and Suppresses DNA Double Strand Break Repair
- (2010) Sung-Hwan Moon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Escape from p53-mediated tumor surveillance in neuroblastoma: switching off the p14ARF-MDM2-p53 axis
- (2009) T Van Maerken et al. CELL DEATH AND DIFFERENTIATION
- PPM1D Is a Potential Therapeutic Target in Ovarian Clear Cell Carcinomas
- (2009) D. S.P. Tan et al. CLINICAL CANCER RESEARCH
- Antitumor Activity of the Selective MDM2 Antagonist Nutlin-3 Against Chemoresistant Neuroblastoma With Wild-Type p53
- (2009) Tom Van Maerken et al. JNCI-Journal of the National Cancer Institute
- Targeted Molecular Therapy for Neuroblastoma: The ARF/MDM2/p53 Axis
- (2009) Eugene Kim et al. JNCI-Journal of the National Cancer Institute
- Wip1 Regulates the Generation of New Neural Cells in the Adult Olfactory Bulb through p53-Dependent Cell Cycle Control
- (2009) Yun-Hua Zhu et al. STEM CELLS
- Senescent Growth Arrest in Mesenchymal Stem Cells Is Bypassed by Wip1-Mediated Downregulation of Intrinsic Stress Signaling Pathways
- (2009) Ji-Seon Lee et al. STEM CELLS
- WIP1 phosphatase at the crossroads of cancer and aging
- (2009) Xavier Le Guezennec et al. TRENDS IN BIOCHEMICAL SCIENCES
- The type 2C phosphatase Wip1: An oncogenic regulator of tumor suppressor and DNA damage response pathways
- (2008) Xiongbin Lu et al. CANCER AND METASTASIS REVIEWS
- Regenerative capacity of neural precursors in the adult mammalian brain is under the control of p53
- (2007) Silvia Medrano et al. NEUROBIOLOGY OF AGING
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started